On February 10, the U.S. Securities and Exchange Commission proposed two amendments to the rules governing its whistleblower program, Exchange Act Rules 21F-3 and 6. “These amendments, if adopted, would help ensure that...more
Delaware Court of Chancery Declines to Dismiss Investment Firm from Stockholder Derivative Suit; Delaware Chancery Court Dismisses Majority of Claims Alleging that California Biotech Firm Profited from Nonpublic Information...more
12/23/2021
/ Aiding and Abetting ,
Bad Faith ,
Biotechnology ,
Board of Directors ,
Breach of Duty ,
Class Action ,
Conflicts of Interest ,
Coronavirus/COVID-19 ,
Derivative Suit ,
Dismissals ,
False Statements ,
Fiduciary Duty ,
Investment Firms ,
Investors ,
Misleading Statements ,
Motion to Dismiss ,
Non-Public Information ,
Proxy Statements ,
Publicly-Traded Companies ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Fraud ,
Securities Violations ,
Shareholders ,
Stock Prices ,
Unjust Enrichment ,
Vaccinations
Delaware Federal Court Dismisses Shareholder Derivative Suit Concerning Lack of Board Diversity; California Federal Court Dismisses Shareholder Class Action Against Sorrento Therapeutics Regarding COVID-19 Treatment; Delaware...more
12/23/2021
/ Board of Directors ,
Cannabis-Related Businesses (CRBs) ,
Class Action ,
Coronavirus/COVID-19 ,
Derivative Suit ,
Discovery ,
Discovery Violations ,
Dismissals ,
Diversity ,
False Statements ,
Investment Fraud ,
Investors ,
Misleading Statements ,
Misrepresentation ,
Pharmaceutical Industry ,
Popular ,
Putative Class Actions ,
Rule 10b-5 ,
Scienter ,
Securities Exchange Act of 1934 ,
Securities Violations ,
Shareholder Litigation ,
Shareholders
Delaware Court of Chancery Finds that Director’s Email on Outside Email System Remains Confidential; Delaware Supreme Court Overrules Longstanding Precedent Regarding Derivative Versus Direct Standing; SEC Files Crowdfunding...more
10/8/2021
/ Anti-Fraud Provisions ,
Attorney-Client Privilege ,
Board of Directors ,
Cannabis-Related Businesses (CRBs) ,
Class Action ,
Crowdfunding ,
DE Supreme Court ,
Demand Futility ,
Derivative Suit ,
Dilution ,
Dismissals ,
Email ,
Enforcement Actions ,
Facebook ,
Failure To Disclose ,
FDA Approval ,
Investors ,
Mark Zuckerberg ,
Minority Shareholders ,
Misleading Statements ,
Omissions ,
Putative Class Actions ,
Securities Act of 1933 ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act of 1934 ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Unregistered Securities
Northern District of California Dismisses Traders’ Suit Against Bitmex Crypto Exchange with Prejudice; Delaware Supreme Court Upholds Chancery Court Ruling That Stockholder Appraisal Rights Can Be Waived by Contract;...more
9/22/2021
/ Appraisal Rights ,
Article III ,
Civil Monetary Penalty ,
Cryptocurrency ,
DE Supreme Court ,
Delaware General Corporation Law ,
Derivatives ,
Dismissal With Prejudice ,
Material Misrepresentation ,
Rule 10b-5 ,
Section 262 ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act of 1934 ,
Securities Fraud ,
Securities Litigation ,
Securities Transactions ,
Securities Violations ,
Settlement ,
Shareholder Rights ,
Standing ,
Stockholder Agreements ,
Waiver of Rights